Haryana · State Subsidy
Haryana Pharmaceutical and Medical Devices Manufacturing Policy 2026
- Maximum benefit
- 20–30% of eligible CAPEX (up to ₹200 Crore) + 50–80% of eligible OPEX for 10 years (up to ₹20 Crore/yr)
- Who can apply
- Micro, Small, Medium enterprises, for specific activities only
- Status
- Open; current term ends 26 May 2031
Is Pharma & Medical Devices 2026 open? Key facts at a glance
Pharma & Medical Devices 2026 (Haryana): 20–30% of eligible CAPEX (up to ₹200 Crore) + 50–80% of eligible OPEX for 10 years (up to ₹20 Crore/yr).
Last verified: 17 Oct 2026. How we check our information
| Status | Open |
|---|---|
| Level | Haryana State scheme |
| Type of benefit | CAPEX Support + OPEX Support + Export, Patent and Green Incentives |
| Maximum benefit | 20–30% of eligible CAPEX (up to ₹200 Crore) + 50–80% of eligible OPEX for 10 years (up to ₹20 Crore/yr) |
| Project cost range | Any |
| Who can apply | Micro, Small, Medium enterprises (Manufacturing). Only for: Only units manufacturing pharmaceutical products (APIs, key starting materials, drug intermediates, bulk drugs, formulations), biologics, biosimilars or medical devices as defined by the Government of India, holding the licences required under the Drugs and Cosmetics Act and the Medical Devices Rules. |
| Implementing agency | Department of Industries & Commerce, Haryana |
| Where to apply | Invest Haryana (HEPC) portal |
| Official notification | Read the notification (PDF) · notified 27 May 2026 |
| Current term ends | 26 May 2031 |
| Last verified | 17 Oct 2026 · How we check |
What is Pharma & Medical Devices 2026?
Notified on 27 May 2026 (Haryana Govt. Gazette Extraordinary No. 81-2026/Ext, notification No. 20/09/2026-4IB-1) for five years.
It covers units manufacturing pharmaceutical products (APIs, key starting materials, drug intermediates, bulk drugs and formulations), biologics, biosimilars and medical devices as defined by the Government of India, with the licences required under the Drugs and Cosmetics Act 1940, its Rules and the Medical Devices Rules 2017.
Only units that begin commercial production after the policy was notified are eligible, and the application must be made before commercial production starts.
Existing units qualify for one expansion or diversification at the same location with additional FCI of at least 50% of current FCI (or 25% with at least ₹125 Crore, or above the Mega threshold). Area categories follow the Make in Haryana Industrial Policy.
CAPEX Support: 30% of eligible capital expenditure in Prime/Focus and Sub-Prime Areas, 25% in Intermediate and 20% in Core Areas, up to ₹200 Crore per unit, in ten annual instalments; eligible CAPEX covers building and infrastructure, plant and machinery including tools, dies, moulds, jigs and fixtures, IT hardware and software, captive renewable energy of at least 100 kW, ETP/waste management/air pollution control, technology acquisition (up to ₹1 Crore a year), stamp duty and external development charges.
OPEX Support: 80% of eligible operating expenditure in Prime/Focus, 70% in Sub-Prime, 60% in Intermediate and 50% in Core Areas, for ten years, up to ₹20 Crore per unit per year — covering Net SGST and electricity duty paid to Haryana, 75% of lease rent (capped at 6% of the property's valuation), quality certifications (e.g. GMP, WHO-GMP, USFDA, CE, BIS, CDSCO), clinical trials, up to five BA/BE studies a year, patent costs, CGTMSE guarantee fees, credit rating fees, and export freight at 1% of FOB value (up to ₹1 Crore a year).
Exporters choose one export incentive: a CAPEX booster of 5% × (export share of sales − 10%) for units with at least 10% exports and ₹100 Crore average turnover in the first three years, or 3% of annual export value for five years, capped at 4.5% of eligible CAPEX.
Commercialised patents earn ₹50 lakh each (domestic, up to ₹5 Crore) or ₹1 Crore each (foreign, up to ₹10 Crore).
Green incentives: ₹100 per carbon credit (up to ₹1 Crore), captive renewable energy ₹50 lakh per MW (up to ₹2.5 Crore for MSME/Large units), 50% of ZLD cost (up to ₹5 Crore for MSME/Large units) and 2% of building cost for green certification (up to ₹5 Crore).
The policy also has the local employment subsidy and HKRN EPF reimbursement, 50% of intern stipends, a relocation grant of 50% of shifting costs (up to ₹5 Crore from another State, ₹10 Crore from abroad), prototyping support for startups, and park-developer incentives.
A unit receiving a Government of India PLI or similar scheme may instead take a 50% top-up on the Central benefit, in place of the State incentives.
The same project cannot claim under another Haryana policy, except the Progressive MSME policy for heads not covered here, and total incentives with Central assistance are capped at 100% of FCI.
Official notification (PDF) · notified 27 May 2026
What are the key benefits of Pharma & Medical Devices 2026?
- CAPEX Support: 30% of eligible capital expenditure in Prime/Focus and Sub-Prime Areas, 25% in Intermediate and 20% in Core Areas, up to ₹200 crore per unit, paid in ten annual instalments.
- OPEX Support for ten years: 80% (Prime/Focus), 70% (Sub-Prime), 60% (Intermediate) or 50% (Core) of eligible operating costs such as Net SGST, electricity duty, lease rent, quality certifications, clinical trials, BA/BE studies, patents and export freight, up to ₹20 crore a year.
- Export incentive (one option): a CAPEX booster of 5% × (export share − 10%), or 3% of annual export value for five years capped at 4.5% of eligible CAPEX.
- Commercialised patents: ₹50 lakh per domestic patent (up to ₹5 crore) and ₹1 crore per foreign patent (up to ₹10 crore).
- Green incentives: ₹100 per carbon credit (up to ₹1 crore), ₹50 lakh per MW of captive renewable energy (up to ₹2.5 crore for MSME/Large units), 50% of ZLD cost (up to ₹5 crore for MSME/Large units), 2% of building cost for green certification (up to ₹5 crore).
- Employment subsidy for Haryana local employees for ten years, HKRN EPF reimbursement (up to ₹25,000 per employee a year for five years) and 50% of intern stipends (up to ₹15,000 a month).
What could a unit get under Pharma & Medical Devices 2026?
The ceiling the scheme sets. What a particular unit receives depends on its project cost, location and the conditions on this page, so no rupee figure is worked out here.
Up to the scheme’s limits: 20–30% of eligible CAPEX (up to ₹200 Crore) + 50–80% of eligible OPEX for 10 years (up to ₹20 Crore/yr)
Illustrative only: this is the scheme’s maximum, not an estimate for your unit. Source: Haryana Pharmaceutical and Medical Devices Manufacturing Policy 2026 — Haryana Govt. Gazette (Extra.) No. 81-2026/Ext, 27 May 2026 (notification No. 20/09/2026-4IB-1).
Who can apply for Pharma & Medical Devices 2026?
- Manufacturers of pharmaceutical products (APIs, KSMs, drug intermediates, bulk drugs, formulations), biologics, biosimilars and medical devices, with the required drug or device licences.
- New units starting commercial production after 27 May 2026, during the policy period; existing units for one expansion at the same location with additional FCI of at least 50% of current FCI (or 25% with at least ₹125 crore).
- The application must reach the Department before commercial production starts.
- Rates depend on the area category (Prime/Focus, Sub-Prime, Intermediate, Core) under the Make in Haryana Industrial Policy.
Eligible business types
MSME categories covered
Eligible industries
How do I apply for Pharma & Medical Devices 2026?
- Apply on the Invest Haryana (HEPC) portal before commercial production or operations begin — the policy does not accept applications afterwards.
- After commencement, claim each instalment or year of support with the supporting expenditure records.
- The policy said its schemes and operational guidelines would be notified within three months of notification (by late August 2026). None had been published on the Department's website when last checked on 20 October 2026, so confirm the application form and documents with the Department of Industries & Commerce. The policy says an application consistent with it is not barred because a scheme has not been notified.
Apply at: Invest Haryana (HEPC) portal
Which documents are needed for Pharma & Medical Devices 2026?
- Application to the Department before commencement of commercial production
- Detailed Project Report
- Drug manufacturing or medical device manufacturing licence
- CA-certified eligible capital expenditure
- Land purchase/lease deed (area category)
- GSTIN and GST returns (for the OPEX claim)
- Statutory auditor certificate of export turnover (for the export incentive)
Can Pharma & Medical Devices 2026 be combined with other schemes?
This scheme can be combined with the following for higher total benefits:
Why are Pharma & Medical Devices 2026 applications rejected?
- Product outside the pharmaceutical or medical device categories defined by the Government of India
- Commercial production started before the policy was notified
- Application filed after commencement of commercial production
- Same incentive head also claimed under another Haryana policy
- Transferred machinery or equipment counted towards CAPEX
Subsidy Setu's DPR preparation process addresses all common rejection points before filing.
Frequently asked questions about Pharma & Medical Devices 2026
- Is Pharma & Medical Devices 2026 open?
- Yes. The current term runs until 26 May 2031. Status last verified: 17 Oct 2026.
- Who can apply for Pharma & Medical Devices 2026?
- Micro, Small, Medium enterprises (Manufacturing). Only for: Only units manufacturing pharmaceutical products (APIs, key starting materials, drug intermediates, bulk drugs, formulations), biologics, biosimilars or medical devices as defined by the Government of India, holding the licences required under the Drugs and Cosmetics Act and the Medical Devices Rules.
- What is the maximum benefit under Pharma & Medical Devices 2026?
- 20–30% of eligible CAPEX (up to ₹200 Crore) + 50–80% of eligible OPEX for 10 years (up to ₹20 Crore/yr).
- How do I apply for Pharma & Medical Devices 2026?
- 1. Apply on the Invest Haryana (HEPC) portal before commercial production or operations begin — the policy does not accept applications afterwards. 2. After commencement, claim each instalment or year of support with the supporting expenditure records. 3. The policy said its schemes and operational guidelines would be notified within three months of notification (by late August 2026). None had been published on the Department's website when last checked on 20 October 2026, so confirm the application form and documents with the Department of Industries & Commerce. The policy says an application consistent with it is not barred because a scheme has not been notified. Apply at: Invest Haryana (HEPC) portal.
- Until when can I apply for Pharma & Medical Devices 2026?
- The current term runs until 26 May 2031. Projects must usually be registered or commence within the term; check the cut-off before you rely on it.
Related schemes
Want this subsidy? Talk to our expert team
Leave your name and mobile number. Our team calls you back within one working day (Monday to Saturday).
Your details are never sold; they are shared only as our Privacy Policy describes.